Viewing Study NCT00149851


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-01-13 @ 7:49 AM
Study NCT ID: NCT00149851
Status: COMPLETED
Last Update Posted: 2010-09-01
First Post: 2005-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Symptomatic Gastroespohageal Reflux Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GERD, heartburn, regurgitation, reflux disease View